We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Neutropenia and latrogenic Neutrophil Dysfunction in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome-Reply

Richard D. Moore, MD, MHSc; Richard E. Chaisson, MD
Arch Intern Med. 1996;156(13):1476. doi:10.1001/archinte.1996.00440120141018.
Text Size: A A A
Published online


We appreciate the comments of Arnott and colleagues. We would like to point out that the controlled trial of Hardy et al1 did show a statistically significant decrease not only in the log rank statistic comparing time with development of bacterial infection, but also in the frequency of infection (19 of 154 patients receiving trimethoprimsulfamethoxazole vs 38 of 156 patients receiving aerosol pentamidine; Fisher exact test, P=.005). Therefore, we believe that it was appropriate to adjust for the use of trimethoprim-sulfamethoxazole in adult HIV-infected patients. In regard to use of pentamidine in our patients, there was no appreciable use of intravenous pentamidine during the relevant period in cases and controls. There was use of aerosol pentamidine for prophylaxis of P carinii pneumonia in some patients, but it is probably less likely that the inhaled form of the drug would be a confounding variable for bacterial pneumonia, particularly since


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.